Thursday 20/January/2022 06:15 AM
SEC recommends regular market approval to Covaxin, Covishield for adults
New Delhi: The Drugs Controller General of India's (DCGI) subject expert committee (SEC) has recommended the regular market approval to Serum Institute of...